ICH E8(R1) Critical-to-Quality Endpoints: Protocol Design Rules
A methodological guide to identifying critical-to-quality endpoint factors under ICH E8(R1) and locking definitions, estimands, and feasibility before protocol freeze.
19 minBy
Topic · Page 2
clinical-trials
Clinical trial design and execution.
Content Validity for Trial Endpoints: Using PFDD Guidance 2 to Identify What Matters
A methodological guide to FDA PFDD Guidance 2 for trial teams to elicit patient-reported disease and treatment burdens before assuming an existing questionnaire defines the concept of interest.
23 minBy
MedConsumablesGuide: Reviewing Trial Kit Substitutions Before Collection
A clinical trial guide for reconciling protocol and lab-manual identity when offered substitute collection kits, separating transport compliance from endpoint assay comparability.
19 minBy
PharmaDossier: Mapping Coverage Gaps to Trial Treatment Interruptions
A structured clinical trial guide for documenting therapy identity, supply responsibility, and actual exposure when routine-care or background regimens encounter insurance coverage delays before biostatisticians classify an intercurrent event.
20 minBy
PRO, ClinRO, ObsRO, or PerfO: Choosing the COA Type for the Concept of Interest
A methodological decision framework for clinical trialists to select among PRO, ClinRO, ObsRO, and PerfO measures based on the concept of interest and context of use before naming an instrument.
20 minBy
MedDeviceRepair: Assessing Endpoint Data After Analyzer Service
A structured guide for trial endpoint leads, laboratories, and biostatisticians on evaluating endpoint observations after an analyzer service event, separating equipment release from data review and SAP handling under 42 CFR 493, ICH E6(R3), and ICH E9(R1).
30 minBy
Statistical Analysis Plans for Endpoints: What Must Be Locked Before Unblinding
A methodological guide for biostatistics and clinical development teams on what endpoint definitions, estimand-aligned estimators, and sensitivity analyses the SAP must lock before unblinding.
21 minBy
ClinRO Rater Training and Drift: Controls That Keep an Endpoint Interpretable
A methodological framework for clinical operations, biostatistics, and outcome-assessment teams to qualify, train, and monitor ClinRO raters—preventing endpoint drift without relying on start-up certification alone.
22 minBy
EClinCloud eCOA Change Control: What a Protocol Amendment Must Resolve Before Release
A practical release framework for endpoint and data management leads: separating eCOA measurement alterations from schedule and configuration changes under 21 CFR 312.30, 21 CFR 56.108, final PFDD Guidance 3, and EMA Annex 2.10.
20 minBy
eCOA Mode Comparability: When Mixed Paper, App, and Web Collection Needs New Evidence
A methodological guide for clinical development and biostatistics teams to evaluate measurement comparability across paper, tablet, smartphone, and web modes under the 2023 ISPOR Task Force rule and October 2025 FDA PFDD Guidance 3.
22 minBy
Validating Computerized Systems That Capture Endpoints: Risk-Based Evidence Beyond Part 11
A practical framework for clinical development and quality teams to validate computerized systems capturing trial endpoints—distinguishing platform qualification from protocol configuration under FDA 2024 and EMA 2023 guidelines.
20 minBy
Fit-for-Purpose COAs: Using FDA PFDD Guidance 3 to Select or Modify an Instrument
A practical framework for evaluating clinical outcome assessment fitness for purpose under FDA's final PFDD Guidance 3, spanning instrument selection, modification, and evidentiary rationales.
10 minBy
